Welcome to LookChem.com Sign In|Join Free
The company logo of Shanghai Upbio Tech Co.,Ltd(expird)

Shanghai Upbio Tech Co.,Ltd(expird)

Free supplier Enterprise Certification

Free
supplier
12th
years

Shanghai Upbio Tech Co.,Ltd(expird)

Business Type:Lab/Research institutions

Audited Supplier

Main Products:
Year Established:
2013
Home>>Products>>Hydroxychloroquine sulfate/747-36-4

Product Certification&
Enterprise Certification

More Detail

Shanghai Upbio Tech Co.,Ltd(expird)

Country: China (Mainland)

Business Type:Lab/Research institutions

Hydroxychloroquine sulfate/747-36-4

CAS NO.747-36-4

  • FOB Price: USD: 10.00-10.00 /Gram Get Latest Price
  • Min.Order: 100 Gram
  • Payment Terms: T/T,
  • Available Specifications:

    99%(1-100)Gram

Contact Supplier

Product Details

Keywords

  • Hydroxychloroquine sulfate
  • 747-36-4
  • Apis

Quick Details

  • ProName: Hydroxychloroquine sulfate/747-36-4
  • CasNo: 747-36-4
  • Molecular Formula: C18H26ClN3O - H2SO4
  • Appearance: white crystalline powder
  • Application: 1,Systemic lupus erythematosus (SLE) ...
  • DeliveryTime: 3days
  • PackAge: 10g/pack,100g/pack,1kg/pack
  • Port: Shanghai port
  • ProductionCapacity: 100000 Kilogram/Year
  • Purity: 99%min
  • Storage: dry and cool place
  • Transportation: By AIR,EMS
  • LimitNum: 100 Gram

Superiority

 1.In No Less five years exporting experience.

 

2.Lower Price with higher quality

 

3,Free sample

 

4,We are sincerely responsible for the "product quality" and "After Service"

 

Onchem (China) Co.,Ltd  is Specialized in APIs, chemical intermediates, herbal extract and pharmaceutical raw materials.

 

Details

 

(1) Company Introduction:

 

    Onchem (China) Co.,Ltd  is a comprehensive manufacturer and an international distribution of chemicals throughout the 

 

world. Specialized in APIs, chemical intermediates, herbal extract and pharmaceutical raw materials. our products sell

 

well in Europe, U.S.A., Japan and Korea, Southeast Asia, Taiwan and other country.

 

(2) Product Detail 

 

Hydroxychloroquine sulfate


CAS NO.747-36-4


M.F:C18H28ClN3O5S


M.W:433.95


Appearance:white crystalline powder


Purity:>99%

 

Used for APIs

  

 acter :

 

   This product is white white crystalline powder, odourless, taste bitter. Her face in the water, in ethanol, almost insoluble

 

in chloroform .

 

 

 

Delivery: 3days by EMS,FEDEX,DHL.

 

    Welcome to Onchem (China) Co.,Ltd, and welcome to inquiry me about all our products, we will provice the 

 

competitive price for u. We are sincerely responsible for the "product quality" and "After Service"

 

 

(3) Application

 

  Hydroxychloroquine sulfate was synthesized from Surrey Hammer in 1946. Hydroxychloroquine sulfate has antipyretic,

 

arthritis eliminate rash inhibition, its anti-inflammatory immune suppression immune regulating mechanism in the complex. In

 

the 1950 s, along with antimalarial drugs in systemic lupus erythematosus (SLE) rheumatoid arthritis (RA) is the

 

application of the treatment, the curative effect of hydroxychloroquine sulfate used in the treatment of the rheumatic

 

diseases fsure. Hydroxychloroquine sulfate used in systemic lupus erythematosus (SLE) rheumatoid arthritis (RA) so on

 

the treatment of rheumatism, safe, effective well tolerated. Since the 1990 s, more than 90% of clinical treatment of

 

rheumatism choose hydroxychloroquine sulfate.

 

1, Systemic lupus erythematosus (SLE)

 

      Hydroxychloroquine in the treatment of discoid lupus erythematosus (SLE) the effect of SLE. [3] found applications

 

such as Liang Lirong hydroxychloroquine sulfateal discoid lupus erythematosus (sle) curative effect good, before treatment

 

was significantly improved in patients with various signs, mild adverse reactions.

 

   2, Rheumatoid arthritis (RA)

 

      Hydroxychloroquine sulfate in the treatment of RA curative effect, can improve the symptoms of RA, extremely low

 

incidence of adverse reactions. A study of hydroxychloroquine sulfate long-term treatment of retrospective study [12] to

 

observe the curative effect of 366 RA patients, according to the results of research fa period of eight years follow-up

 

hydroxychloroquine sulfate used in short-term treatment is more valuable. Continuous administration treatment adherence

 

in December to 63%, down to 46%, 24 months of termination of the treatment group the main reason is long-term drug

 

failure after taking this medicine.

 

     In view of the safety of hydroxychloroquine sulfate long-term treatment, clinical recommendations fnew onset of light

 

RA patients, fcombination therapy with other slow-acting drug rheumatism. Hydroxychloroquine sulfate with

 

methotrexate, willow nitrogen sulfanilamide pyridine ringt application of spore, has become a clinical recognized 

 

(4) Factory Picture:

 

 
Hot Product